Why Standard Vendor Contracts Miss AI Agent Risk
Most enterprise software agreements were written for static applications with fixed functionality and predictable data flows. AI systems, particularly agentic tools that call external tools, query data sources, or take autonomous actions, do not fit that model. NIST's Generative AI Profile identifies autonomous decision-making and tool use as distinct risk areas, separate from traditional software failure modes. OWASP's LLM risk taxonomy names this specific failure pattern "Excessive Agency," describing harm that occurs when a system is granted more permissions, tools, or autonomy than a given task requires.
For health systems, this matters because AI agents are increasingly embedded in clinical documentation, scheduling, and administrative workflows where unscoped access to systems or data carries operational and compliance consequences. NIST's Generative AI Profile also identifies value chain and component integration as a risk area in its own right, noting that organizations deploying third-party AI inherit risk from the vendor's design choices and data handling practices. A procurement contract that does not address agent-specific permissioning and vendor-inherited risk leaves these exposures unmanaged regardless of how strong the vendor's general security posture appears.
Mapping Clauses to Existing Regulatory Frameworks
Procurement teams do not need to invent new legal categories from scratch. NIST's AI Risk Management Framework structures risk management around four functions (Govern, Map, Measure, and Manage), and vendor contract obligations can be organized against this structure to keep clause categories aligned with an established framework rather than ad hoc requirements.
HIPAA's audit-control requirement already applies to any system, vendor-operated or not, that processes electronic protected health information, so contracts should make explicit that this obligation extends to AI agents and their supporting infrastructure. Where a vendor's product qualifies as a certified health IT module or predictive decision support intervention under HHS ONC's HTI-1 rule, transparency disclosures should be a contractual guarantee rather than an informal offering, since HTI-1 obligations are specific to that category and do not automatically extend to every AI tool a health system procures. Confirming applicability on a per-system basis avoids assuming HTI-1 coverage where it does not apply.
Negotiation Practices for Procurement Teams
- Request agent permission and tool-call documentation before contract execution, not after deployment begins.
- Require log export capability independent of vendor retention policy, so incident investigation does not depend on vendor cooperation after the fact.
- Establish a recurring review cadence for agent permissions rather than a one-time onboarding assessment.
- Specify notification timelines in days, not general language, for security incidents and model or tool changes.
- Include right-to-audit language distinct from standard SOC 2 or certification references, since those attestations do not address agent-specific permissioning.
Tradeoffs and Practical Limitations
Public guidance from NIST, CISA, NSA, and OWASP provides risk categories and control principles, but none of these sources supply ready-made contract clause language. Translating a risk category like Excessive Agency or a control family like NIST SP 800-53's Audit and Accountability requirements into binding legal terms requires interpretation by procurement and legal teams working together.
There is also no single authoritative source that specifies contractual standards for AI agent accountability terms specifically; current practice draws on adjacent security and risk-management guidance rather than AI-specific contracting law.